Specify a stock or a cryptocurrency in the search bar to get a summary
Alpha Tau Medical Ltd
DRTSAlpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel. Address: Kiryat Hamada Street 5, Jerusalem, Israel, 9777605
Analytics
WallStreet Target Price
9.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DRTS
Dividend Analytics DRTS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DRTS
Stock Valuation DRTS
Financials DRTS
Results | 2019 | Dynamics |